Farah Javed

Farah Javed

Auto-generated profile, based on publicly available information

Farah Javed

Department of Public Health Institute of Social and Cultural Studies University of the Punjab Lahore Pakistan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Efood
Verified
Journal Article
Open access
ESEsha Saeed
Esha Saeed
FJFarah Javed
Farah Javed
ZRZoya Rana
Zoya Rana
RPRashida Perveen
Rashida Perveen
IMIftikhar Younis Mallhi
Iftikhar Younis Mallhi
EAEsther Ugo Alum
Esther Ugo Alum
Pomegranate (Punica granatum L.) is a nutritionally dense fruit containing antioxidants and bioactive compounds, demonstrating significant potential in preventing and managing cardiovascular diseases (CVDs). This review evaluates the vasculoprotective effects of various pomegranate components, including the fruit arils, seeds, peel, and flower extracts. The arils and seeds are abundant in anthocyanins, ellagic acid, and polyphenols, while the peel and flower extracts contain high concentrations of punicalagin, gallic acid, and other potent polyphenols. Human and animal studies have consistently demonstrated that pomegranate consumption can lower blood pressure, improve lipid profiles, and reduce inflammation. Researchers found that daily consumption of should be 50–240 mL of pomegranate juice, 1–1.5 g of peel extract, or 200–500 mg of standardized flower extract. However, due to the high natural sugar content of pomegranate juice and its potential to interact with certain medications, moderate consumption is advised. Overall, pomegranate represents a promising nonpharmacological adjunct in CVD prevention. Further research is needed to optimize its use for maximum cardiovascular benefits. This review highlights pomegranate's potential as a valuable, nonpharmaceutical resource for supporting cardiovascular health.